DR. LOUIS ROSSON III ROBINETT (M.D.) – Rheumatology Physician, NPI 1780002956
Rheumatology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
197 RHEUMATOLOGY in MD
Provider Addresses for DR. LOUIS ROSSON III ROBINETT (M.D.)
1243 GLENEAGLE RD
BALTIMORE, MD 212392236
Phone: (903) 241-6118
Type: Mailing
2227 OLD EMMORTON RD STE 120
BEL AIR, MD 21015
Phone: (410) 897-1941
Fax: (410) 897-1919
Type: Location
2217 PARK BEND DR STE 220
AUSTIN, TX 787585674
Phone: (512) 893-1304
Fax: (512) 265-9011
Type: Mailing
3600 W Parmer Ln Ste 106
Austin, TX 787274107
Phone: (512) 893-1304
Fax: (512) 265-9011
Type: Location
8700 Menchaca Rd Ste 601
Austin, TX 787485377
Phone: (512) 893-1304
Fax: (512) 265-9011
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 135 Open Payments records for all available years, with a total value of $3,543.
Total Amount is formed as General ($3,543) + Research ($0) + Ownership ($0) = $3,543.
Last reported payment date: 2024-12-17 • Largest payer in this snapshot: Amgen Inc. ($544).
Total Amount
$3,543
General + Research + Ownership
Payments
135
Total payment records
General Amount
$3,543
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-17
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Amgen Inc. | $544 |
| ABBVIE INC. | $359 |
| UCB, Inc. | $283 |
| Janssen Biotech, Inc. | $242 |
| Novartis Pharmaceuticals Corporation | $214 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2023-10-09
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20231009000602 | I | Rheumatology | TX | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 43,600 | 18 | $0 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 6,325 | 17 | $0 |
| J0897 | Injection, denosumab, 1 mg | 1,020 | 15 | $0 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 529 | 256 | $0 |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 296 | 42 | $0 |
Insurance plans in this area (ZIP 21239)
Loading plans...
Group practice members
| Name | Specialty | State |
|---|---|---|
| Physician Assistant | TX | |
| Physician Assistant | TX |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.